Literature DB >> 1596197

Cerebral metabolism and depression in patients with complex partial seizures.

E B Bromfield1, L Altshuler, D B Leiderman, M Balish, T A Ketter, O Devinsky, R M Post, W H Theodore.   

Abstract

Twenty-three patients with complex partial seizures were evaluated with 18F-2-deoxyglucose positron emission tomography and with the Beck Depression Inventory. Five of 10 patients with left and zero of eight with right temporal electroencephalographic foci had depressive symptoms; one of five patients with poorly localized electroencephalographic foci also scored in the depressed range. Temporal, frontal, caudate, and thalamic normalized glucose metabolic rates among five patients with depressive symptoms and well-localized left temporal epileptogenic regions were compared with five patients without depressive symptoms but with similar electroencephalographic characteristics. Multifactorial analysis of variance yielded a significant nonlateralized mood by region interaction. Of nine individual regions compared, only inferior frontal cortex showed a significant difference in normalized regional metabolic rate between depressed and nondepressed patients. Metabolism in this region also distinguished patients with depressive symptoms from normal control subjects. Depressive symptoms in patients with complex partial seizures are associated with a bilateral reduction in inferior frontal glucose metabolism, compared with patients without depressive symptoms and normal control subjects. The frontal lobe hypometabolism observed in patients with depressions associated with epilepsy, Parkinson's disease, and primary affective disorder suggests that similar frontal lobe metabolic disturbances could underlie these conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596197     DOI: 10.1001/archneur.1992.00530300049010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  35 in total

Review 1.  The relationship of psychiatric illnesses and seizures.

Authors:  N D Tsopelas; R Saintfort; G L Fricchione
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

2.  Depression in Individuals with Epilepsy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

Review 3.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

4.  Depression in epilepsy: mechanisms and therapeutic approach.

Authors:  Marco Mula; Bettina Schmitz
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

5.  Imaging depression in epilepsy: hints at the biology of despair.

Authors:  Paul A Garcia
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

6.  Alterations in functional connectivity between the hippocampus and prefrontal cortex as a correlate of depressive symptoms in temporal lobe epilepsy.

Authors:  Nobuko Kemmotsu; N Erkut Kucukboyaci; Christopher E Cheng; Holly M Girard; Evelyn S Tecoma; Vicente J Iragui; Carrie R McDonald
Journal:  Epilepsy Behav       Date:  2013-10-28       Impact factor: 2.937

Review 7.  Epilepsy, depression, and growth hormone.

Authors:  Tracy Butler; Patrick Harvey; Lila Cardozo; Yuan-Shan Zhu; Adam Mosa; Emily Tanzi; Fahad Pervez
Journal:  Epilepsy Behav       Date:  2019-02-14       Impact factor: 2.937

8.  Psychiatric care in epilepsy surgery: who needs it?

Authors:  Genevieve Rayner; Sarah J Wilson
Journal:  Epilepsy Curr       Date:  2012-03       Impact factor: 7.500

9.  Cognitive impairment in juvenile myoclonic epilepsy.

Authors:  Sun-Young Kim; Yang-Ha Hwang; Ho-Won Lee; Chung-Kyu Suh; Soon-Hak Kwon; Sung-Pa Park
Journal:  J Clin Neurol       Date:  2007-06-20       Impact factor: 3.077

10.  Temporal lobe epilepsy, depression, and hippocampal volume.

Authors:  Sadat Shamim; Gregor Hasler; Clarissa Liew; Susumu Sato; William H Theodore
Journal:  Epilepsia       Date:  2008-11-19       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.